Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity Among Children Administered Quadrivalent Influenza Vaccine

NCT01240746 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.

NCT NCT01240746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01240746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity Among Children Administered Quadrivalent Influenza Vaccine
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
February 29, 2012
Enrollment
4,363 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

influenza